EP3062809
A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.10.2014EP published:
8.7.2020EP application number:
14802211.4
EPO information:
European Patent Register
Max expiry date:
29.10.2034
Title:
A CXCR4 PEPTIDE INHIBITOR FOR USE IN TREATING ACUTE MYELOID LEUKEMIA WITH A FLT3 MUTATION
Timeline
Today
30.10.2014EP application
8.7.2020EP Publication
Owner
Name:
Biokine Therapeutics Ltd.Address:
Building 13a Einstein Street, Science Park Kiryat Weizmann, 7403617 Nes Ziona, IL
Name:
BioLineRx Ltd.Address:
2 HaMaayan Street, 7177871 Modiin, IL
Inventor
Name:
PELED, AmnonAddress:
6777634 Tel-Aviv, IL
Name:
ABRAHAM, MichalAddress:
9077243 Mevasseret Zion, IL
Priority
Number:
201361897921 PDate:
31.10.2013Country:
US
Number:
201461945302 PDate:
27.2.2014Country:
US
Classification
Categories:
A61K 38/10, A61K 31/5377, A61K 31/7068, A61P 35/00